Author:
Gao Xianchun,Zhao Lulu,Zhang Nannan,Han Weili,Liu Kun,Yan Junya,Chen Ling,Pan Yan,Li Renlong,Li Wenjiao,Zhang Haohao,Li Hongwei,Wang Shibo,Gao Xiaoliang,Niu Penghui,Wang Wanqing,Ji Gang,Zhao Qingchuan,Lu Yuanyuan,Li Zengshan,Shang Lei,Liang Han,Wu Kaichun,Deng Jingyu,Chen Yingtai,Nie Yongzhan,Study Group MAGIS
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference49 articles.
1. Untangling the ErbB signalling network;Y Yarden;Nat Rev Mol Cell Biol. Feb,2001
2. HER2-targeted therapies -a role beyond breast cancer;D Y Oh;Nat Rev Clin Oncol,2020
3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Y J Bang;Lancet. Aug,2010
4. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer;Y Y Janjigian;Nature,2021
5. HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma;Z Liu;J Cancer Res Clin Oncol,2021